{"id":789828,"date":"2023-10-12T02:03:01","date_gmt":"2023-10-12T06:03:01","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/pharming-group-to-report-third-quarter-2023-financial-results-on-october-26\/"},"modified":"2023-10-12T02:03:01","modified_gmt":"2023-10-12T06:03:01","slug":"pharming-group-to-report-third-quarter-2023-financial-results-on-october-26","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/pharming-group-to-report-third-quarter-2023-financial-results-on-october-26\/","title":{"rendered":"Pharming Group to report third quarter 2023 financial results on October 26"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">\n        <strong>Leiden, The Netherlands, October 12, 2023: <\/strong>Pharming Group N.V. (\u201cPharming\u201d) (Euronext Amsterdam: PHARM\/Nasdaq: PHAR) confirms it will report its preliminary (unaudited) third quarter 2023 financial results, for the period ended September 30, on Thursday, October 26, 2023.<\/p>\n<p align=\"justify\">Pharming will host a presentation for analysts and investors at 13:30 CEST\/07:30 EDT on October 26, 2023.<\/p>\n<p align=\"justify\">To participate in the conference call, please register in advance using the link below. Once registered, dial-in information and a unique PIN will be provided, allowing access to the call.<\/p>\n<p align=\"justify\">\n        <strong>Conference call registration:<\/strong>\n      <\/p>\n<p align=\"justify\">\n        <em>Please note, the Company will only take questions from dial-in attendees.<\/em>\n      <\/p>\n<p align=\"justify\">\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=-quCwp5hoJzCdTJmoIY-n5_SZhJ4rsvaeRSbE51JBHDPVhCZOQVDL8pJzPsXXOVVxiCEW9cuF9s0YC6zMHKyVGygnau3lu3T6ZBaamr6rJNZ9DZnW5XmytsSX-K1md-lXPmGEaQPAJEO2z5BlnACXpeZWt7r1gf056GupOv3LPD42v295PiwU2S__e5D-JHl6sTMH70PQjGsriVbw5IwitwPsUCEXglcDsJUpEzJodw=\" rel=\"nofollow noopener\" target=\"_blank\"><br \/>\n          <strong>https:\/\/register.vevent.com\/register\/BIb15561b07c01418199d56096c5c3c8f9<\/strong><br \/>\n        <\/a>\n      <\/p>\n<p align=\"justify\">To watch the live webcast, please register in advance using the link below.<\/p>\n<p align=\"justify\">\n        <strong>Webcast registration: <\/strong>\n      <\/p>\n<p align=\"justify\">\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=-quCwp5hoJzCdTJmoIY-n1dShgPatO53dPquF0BEAGFNbRsj2P9c5P7FUDCNqDO513XpOY0OI66iXblMer0LMTyzojKHwjR6oK8C0P8FkP482QYLYRGB7R3Exd9SYB3TvOfL2_8fn-hjyRccQxqFTD2bdpaem3b_OOydG3OKGqE=\" rel=\"nofollow noopener\" target=\"_blank\"><br \/>\n          <strong>https:\/\/edge.media-server.com\/mmc\/p\/599pzbd7<\/strong><br \/>\n        <\/a>\n      <\/p>\n<p align=\"justify\">\n        <strong>About Pharming Group N.V.<\/strong>\n      <\/p>\n<p align=\"justify\">Pharming Group N.V. (Euronext Amsterdam: PHARM\/Nasdaq: PHAR) is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. Pharming is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines, including small molecules, biologics, and gene therapies that are in early to late-stage development. Pharming is headquartered in Leiden, Netherlands, and has employees around the globe who serve patients in over 30 markets in North America, Europe, the Middle East, Africa, and Asia-Pacific.<\/p>\n<p align=\"justify\">For more information, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=oNQOtjpjsKyO4B8UFB4BkRkQUHDPz5V-R2RpJLQUGUUQS0NMRxxFc8EPgW9p7Tyv0djVt0adR3WYm46fZl6-Y4boncdhbkBZIVAfxDWX-_w=\" rel=\"nofollow noopener\" target=\"_blank\">www.pharming.com<\/a> and find us on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=YmHA_Udx6kK3VZdiYNnIAC4_0gUoFpEbE5AvtYOPdm6kqPGNvkd9rjZ4p0mS-hYdGgaqaoVeb5kVoao6w2w85JXhrgB0zUGTlTBL4fIlUjw=\" rel=\"nofollow noopener\" target=\"_blank\">LinkedIn<\/a>.<\/p>\n<p align=\"justify\">\n        <strong>For further public information, contact:<\/strong>\n      <\/p>\n<p align=\"justify\">\n        <strong><br \/>\n          <em>Pharming Group, Leiden, The Netherlands<\/em><br \/>\n        <\/strong><br \/>\n        <br \/>Michael Levitan, VP Investor Relations &amp; Corporate Communications<br \/>T: +1 (908) 705 1696<\/p>\n<p align=\"justify\">Heather Robertson, Investor Relations &amp; Corporate Communications Manager<br \/>E: investor@pharming.com<\/p>\n<p align=\"justify\">\n        <strong><br \/>\n          <em>FTI Consulting, London, UK<\/em><br \/>\n        <\/strong><br \/>\n        <br \/>Victoria Foster Mitchell\/Alex Shaw\/Amy Byrne<br \/>T: +44 203 727 1000<\/p>\n<p align=\"justify\">\n        <strong><br \/>\n          <em>LifeSpring Life Sciences Communication, Amsterdam, The Netherlands<\/em><br \/>\n        <\/strong><br \/>\n        <br \/>Leon Melens<br \/>T: +31 6 53 81 64 27<br \/>E: pharming@lifespring.nl<\/p>\n<p align=\"justify\">\n        \n      <\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDg0Mzc0OSM0MDE2MjEyODkjMjAwMDk3Ng==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml-eu.globenewswire.com\/media\/NzljMWRkZTItYTIxMS00NWM4LTljZTgtZGViNGZjZjZkNDk5LTEwMTI1NDk=\/tiny\/Pharming-Group-N-V-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Leiden, The Netherlands, October 12, 2023: Pharming Group N.V. (\u201cPharming\u201d) (Euronext Amsterdam: PHARM\/Nasdaq: PHAR) confirms it will report its preliminary (unaudited) third quarter 2023 financial results, for the period ended September 30, on Thursday, October 26, 2023. Pharming will host a presentation for analysts and investors at 13:30 CEST\/07:30 EDT on October 26, 2023. To participate in the conference call, please register in advance using the link below. Once registered, dial-in information and a unique PIN will be provided, allowing access to the call. Conference call registration: Please note, the Company will only take questions from dial-in attendees. https:\/\/register.vevent.com\/register\/BIb15561b07c01418199d56096c5c3c8f9 To watch the live webcast, please register in advance using the link below. Webcast registration: https:\/\/edge.media-server.com\/mmc\/p\/599pzbd7 About Pharming Group N.V. Pharming &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/pharming-group-to-report-third-quarter-2023-financial-results-on-october-26\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Pharming Group to report third quarter 2023 financial results on October 26&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-789828","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Pharming Group to report third quarter 2023 financial results on October 26 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/pharming-group-to-report-third-quarter-2023-financial-results-on-october-26\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharming Group to report third quarter 2023 financial results on October 26 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Leiden, The Netherlands, October 12, 2023: Pharming Group N.V. (\u201cPharming\u201d) (Euronext Amsterdam: PHARM\/Nasdaq: PHAR) confirms it will report its preliminary (unaudited) third quarter 2023 financial results, for the period ended September 30, on Thursday, October 26, 2023. Pharming will host a presentation for analysts and investors at 13:30 CEST\/07:30 EDT on October 26, 2023. To participate in the conference call, please register in advance using the link below. Once registered, dial-in information and a unique PIN will be provided, allowing access to the call. Conference call registration: Please note, the Company will only take questions from dial-in attendees. https:\/\/register.vevent.com\/register\/BIb15561b07c01418199d56096c5c3c8f9 To watch the live webcast, please register in advance using the link below. Webcast registration: https:\/\/edge.media-server.com\/mmc\/p\/599pzbd7 About Pharming Group N.V. Pharming &hellip; Continue reading &quot;Pharming Group to report third quarter 2023 financial results on October 26&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/pharming-group-to-report-third-quarter-2023-financial-results-on-october-26\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-10-12T06:03:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDg0Mzc0OSM0MDE2MjEyODkjMjAwMDk3Ng==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pharming-group-to-report-third-quarter-2023-financial-results-on-october-26\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pharming-group-to-report-third-quarter-2023-financial-results-on-october-26\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Pharming Group to report third quarter 2023 financial results on October 26\",\"datePublished\":\"2023-10-12T06:03:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pharming-group-to-report-third-quarter-2023-financial-results-on-october-26\\\/\"},\"wordCount\":290,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pharming-group-to-report-third-quarter-2023-financial-results-on-october-26\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDg0Mzc0OSM0MDE2MjEyODkjMjAwMDk3Ng==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pharming-group-to-report-third-quarter-2023-financial-results-on-october-26\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pharming-group-to-report-third-quarter-2023-financial-results-on-october-26\\\/\",\"name\":\"Pharming Group to report third quarter 2023 financial results on October 26 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pharming-group-to-report-third-quarter-2023-financial-results-on-october-26\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pharming-group-to-report-third-quarter-2023-financial-results-on-october-26\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDg0Mzc0OSM0MDE2MjEyODkjMjAwMDk3Ng==\",\"datePublished\":\"2023-10-12T06:03:01+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pharming-group-to-report-third-quarter-2023-financial-results-on-october-26\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pharming-group-to-report-third-quarter-2023-financial-results-on-october-26\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pharming-group-to-report-third-quarter-2023-financial-results-on-october-26\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDg0Mzc0OSM0MDE2MjEyODkjMjAwMDk3Ng==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDg0Mzc0OSM0MDE2MjEyODkjMjAwMDk3Ng==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pharming-group-to-report-third-quarter-2023-financial-results-on-october-26\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pharming Group to report third quarter 2023 financial results on October 26\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pharming Group to report third quarter 2023 financial results on October 26 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/pharming-group-to-report-third-quarter-2023-financial-results-on-october-26\/","og_locale":"en_US","og_type":"article","og_title":"Pharming Group to report third quarter 2023 financial results on October 26 - Market Newsdesk","og_description":"Leiden, The Netherlands, October 12, 2023: Pharming Group N.V. (\u201cPharming\u201d) (Euronext Amsterdam: PHARM\/Nasdaq: PHAR) confirms it will report its preliminary (unaudited) third quarter 2023 financial results, for the period ended September 30, on Thursday, October 26, 2023. Pharming will host a presentation for analysts and investors at 13:30 CEST\/07:30 EDT on October 26, 2023. To participate in the conference call, please register in advance using the link below. Once registered, dial-in information and a unique PIN will be provided, allowing access to the call. Conference call registration: Please note, the Company will only take questions from dial-in attendees. https:\/\/register.vevent.com\/register\/BIb15561b07c01418199d56096c5c3c8f9 To watch the live webcast, please register in advance using the link below. Webcast registration: https:\/\/edge.media-server.com\/mmc\/p\/599pzbd7 About Pharming Group N.V. Pharming &hellip; Continue reading \"Pharming Group to report third quarter 2023 financial results on October 26\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/pharming-group-to-report-third-quarter-2023-financial-results-on-october-26\/","og_site_name":"Market Newsdesk","article_published_time":"2023-10-12T06:03:01+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDg0Mzc0OSM0MDE2MjEyODkjMjAwMDk3Ng==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pharming-group-to-report-third-quarter-2023-financial-results-on-october-26\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pharming-group-to-report-third-quarter-2023-financial-results-on-october-26\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Pharming Group to report third quarter 2023 financial results on October 26","datePublished":"2023-10-12T06:03:01+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pharming-group-to-report-third-quarter-2023-financial-results-on-october-26\/"},"wordCount":290,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pharming-group-to-report-third-quarter-2023-financial-results-on-october-26\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDg0Mzc0OSM0MDE2MjEyODkjMjAwMDk3Ng==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pharming-group-to-report-third-quarter-2023-financial-results-on-october-26\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/pharming-group-to-report-third-quarter-2023-financial-results-on-october-26\/","name":"Pharming Group to report third quarter 2023 financial results on October 26 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pharming-group-to-report-third-quarter-2023-financial-results-on-october-26\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pharming-group-to-report-third-quarter-2023-financial-results-on-october-26\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDg0Mzc0OSM0MDE2MjEyODkjMjAwMDk3Ng==","datePublished":"2023-10-12T06:03:01+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pharming-group-to-report-third-quarter-2023-financial-results-on-october-26\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/pharming-group-to-report-third-quarter-2023-financial-results-on-october-26\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pharming-group-to-report-third-quarter-2023-financial-results-on-october-26\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDg0Mzc0OSM0MDE2MjEyODkjMjAwMDk3Ng==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDg0Mzc0OSM0MDE2MjEyODkjMjAwMDk3Ng=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pharming-group-to-report-third-quarter-2023-financial-results-on-october-26\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Pharming Group to report third quarter 2023 financial results on October 26"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/789828","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=789828"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/789828\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=789828"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=789828"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=789828"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}